Stay updated with breaking news from Risk Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The future of medication abortion access in the United States went in front of the U.S. Supreme Court justices on Tuesday, where several justices appeared somewhat skeptical as anti-abortion organizations argued use of the pharmaceutical should be moved back to what was in place before 2016.
The abortion and miscarriage care drug mifepristone is at the center of a case being heard by the U.S. Supreme Court that seeks to limit access to it. Here is a history of the drug and what's happening now that the Supreme Court has overturned national abortion rights.
Merck shares posted the biggest rise in the Dow Jones index on Wednesday, reaching an all-time high after US health authorities gave the go-ahead for the prescription of its Winrevair to treat...
The Supreme Court’s opinion on the case will likely arrive sometime early this summer.